Spermspecific protein 411 (SSP411) is one such protein which is elevated in the bile of CCA patients and recently found to successfully distinguish CCA from choledocholithiasis as a single serum-based biomarker [232]. This evidence concerns the gene SPATA20 and cholangiocarcinoma.